Best High Tech Stocks To Watch Right Now

With shares of CVS Caremark (NYSE:CVS) trading around $57, is CVS an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

CVS Caremark�is a pharmacy healthcare provider in the United States.�The company operates in three business segments: Pharmacy Services, Retail Pharmacy, and Corporate. The products and services offered at CVS Caremark stores may be deemed as essential by many consumers in the United States. As CVS Caremark provides an efficient and affordable healthcare and pharmacy experience, look for it to see rising profits. The healthcare sector is seeing a massive change that may benefit companies like this one for many years.

T = Technicals on the Stock Chart are Strong

CVS Caremark stock has witnessed a powerful move over the last several years. The stock is now consolidating near all-time high prices and might get going after it digests recent gains. Analyzing the price trend and its strength can be done using key simple moving averages. What are the key moving averages? The 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, CVS Caremark is trading near its rising key averages which signal neutral to bullish price action in the near-term.

Top Gold Companies To Own In Right Now: Prothena Corporation PLC (PRTA)

Prothena Corporation PLC, incorporated on September 26, 2012, is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion. Its pipeline includes NEOD001, PRX002 and PRX003. The Company�� work in protein misfolding could result in therapies to treat several neurodegenerative diseases, including AL (primary) and AA (secondary) forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002). Its cell adhesion development activities could generate new therapies to treat inflammatory diseases and metastatic cancers (PRX003). The Company�� program, NEOD001, is in Phase 1. In addition to antibodies directed to neo-epitope targets, it is developing antibodies directed to other targets. The Company has generated antibodies against cell adhesion targets expressed on certain pathogenic Th17 immune cells and tumor cells.

The Company�� pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of disease. It is also generating additional antibodies against other targets involved in protein misfolding and cell adhesion for characterization in vivo and in vitro.

NEOD001 for Amyloidosis

NEOD001 is a monoclonal antibody that targets the amyloid that accumulates in both AL and AA forms of amyloidosis. The antibody was designed to not react with normal serum amyloid A and only with the aberrant cleaved form of the protein (amyloid A).

PRX002 for Parkinson�� Disease

The Company has generated antibodies targeting alpha-synuclein that may slow or reduce the neurodegeneration associated with synuclein misfolding and/or transmission. It has tested these antibodies in various cellular and animal models of synuclein-related disease. In a transgenic mouse model of Parkinson�� disease, passive immunization with 9E4, a murine ver! sion of PRX002, reduced the appearance of synuclein pathology, protected synapses and improved performance by the mice in behavioral testing. The humanized antibody product candidate PRX002 has advanced into manufacturing and preclinical testing.

PRX003 for Inflammatory Diseases and Cancers

The Company is developing PRX003, a monoclonal antibody targeting MCAM for the potential treatment of inflammatory diseases and cancers. It has generated monoclonal antibodies that block MCAM-mediated cell adhesion and have been shown to delay relapse and severity of relapse in a mouse model of multiple sclerosis known as experimental autoimmune encephalomyelitis. The Company�� antibodies are being tested in animal models of inflammatory diseases and cancers. Based on early results from these studies, it has identified a clinical candidate, PRX003. It has advanced this antibody into manufacturing and intends to advance this antibody into preclinical testing.

Advisors' Opinion:

• [By Michael Robinson]

  CSD is also tapping into the biotech boom. Another firm that it holds, and we like, is Prothena Corporation PLC (PRTA), a clinical-stage biotechnology firm focused on Parkinson's disease and other neurodegenerative disorders.

• [By MONEYMORNING]

  For its part, CSD also is tapping into the biotech boom. The second firm that it holds and we like is Prothena Corporation PLC (Nasdaq: PRTA), a clinical-stage biotechnology firm focused on Parkinson's disease and other neurodegenerative disorders.

• [By Lisa Levin]

  Prothena Corporation plc (NASDAQ: PRTA) rose 24.40% to $46.23 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.

• [By Jake L'Ecuyer]

  Shares of Prothena Corporation plc (NASDAQ: PRTA) got a boost, shooting up 6.99 percent to $32.00 after the company reported the successful start of a Phase 1 clinical trial of PRX002 for the treatment of Parkinson's disease. Citigroup initiated coverage on the stock with a Buy rating and a $50.00 price target.

Best High Tech Stocks To Watch Right Now: Marcolin SpA (MCL)

Marcolin SpA is an Italy-based eyewear manufacturer. It is a manufacturer of glasses and sunglasses for such brands as Tom Ford, Roberto Cavalli and Just Cavalli, Diesel, Montblanc, Tod's and Hogan, Balenciaga, Swarovski, Timberland, DSquared2 and Kenneth Cole. Advisors' Opinion:

• [By John McCamant]

  Our top stock selection for 2014 has received three Breakthrough Therapy Designations (BTD) by the FDA, and subsequent approval, in November, for Imbruvica, a very safe pill that has shown unprecedented efficacy to treat mantle cell lymphoma (MCL), suggests John McCamant, editor of The Medical Technology Stock Letter.

Best High Tech Stocks To Watch Right Now: Honda Motor Company Ltd. (HMC)

Honda Motor Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and distribution of motorcycles, automobiles, and power products primarily in North America, Europe, and Asia. Its motorcycle line consists of business and commuter models, as well as sports models, including trial and moto-cross racing; all?terrain vehicles; personal watercrafts; and multi utility vehicles. The company also produces various automobile products, including passenger cars, minivans, multi-wagons, sport utility vehicles, and mini cars; and power products comprising tillers, portable generators, general-purpose engines, grass cutters, outboard marine engines, water pumps, snow throwers, power carriers, power sprayers, lawn mowers and lawn tractors, home-use cogeneration units, and thin film solar cells for home, public, and industrial uses. In addition, it sells spare parts and provides after sales services are through retail dealers, as well as offers retail lendin g and leasing to customers, and wholesale financing to dealers. The company was founded in 1946 and is based in Tokyo, Japan.

Advisors' Opinion:

• [By Chris Katje]

  Back in February, I wrote about SolarCity's deal with Honda Motor Corporation (HMC). Under that deal, $65 million was made available by Honda to help finance over 3000 homes and dealerships. Honda saw the deal as a way to help sell its line of alternative energy vehicles and also change its dealerships to solar power to lower monthly utility costs.

Best High Tech Stocks To Watch Right Now: Summit Midstream Partners LP (SMLP)

Summit Midstream Partners, LP is engaged in owning and operating midstream energy infrastructure that is located in North America. The Company provides natural gas gathering and compression services in two resource basins: the Piceance Basin, which includes the Mesaverde, Mancos and Niobrara Shale formations in western Colorado, and the Fort Worth Basin, which includes the Barnett Shale formation in north-central Texas. As of June 30, 2012, the Company�� gathering systems had approximately 385 miles of pipeline and 147,600 horsepower of compression. As of September 20, 2012, its systems gathered an average of approximately 909 million cubic feet per day of natural gas, of which approximately 64% consisted of natural gas liquids (NGLs), that were extracted by a third party processor. Summit Midstream GP, LLC is the Company�� general partner. On October 27, 2011, the Company acquired certain natural gas gathering pipeline, dehydration and compression assets in the Piceance Basin of western Colorado, which it refer to as the Grand River system. The Company�� customers include the natural gas producers in North America, such as Encana Corporation, Chesapeake Energy Corporation, TOTAL, S.A., Carrizo Oil & Gas, Inc., WPX Energy, Inc., Bill Barrett Corporation, Exxon Mobil Corporation and EOG Resources, Inc. In October 2012, the Company acquired ETC Canyon Pipeline, LLC from La Grange Acquisition, L.P., a wholly owned subsidiary of Energy Transfer Partners, L.P. On February 15, 2013, it closed the acquisition of to Meadowlark Midstream Company, LLC, formerly Bear Tracker Energy, LLC. In June 2013, Summit Midstream Partners LP acquires assets in Bakken, Marcellus. In June 2013, Summit Midstream Partners LP acquired Bison Midstream LLC. In June 2013, Summit Midstream Partners LP closed the previously announced acquisition of certain natural gas gathering pipelines and compression assets located in the liquids-rich window of the Marcellus Shale Play.

The Grand River system consists of approxi! mately 276 miles of pipeline and 97,500 horsepower of compression and is located in Garfield County, Colorado. The Grand River system primarily gathers natural gas produced by the Company�� customers from the liquids-rich Mesaverde formation within the Piceance Basin. The Grand River system also gathers natural gas produced from its customers' wells targeting the deeper Mancos and Niobrara Shale formations. As of September 20, 2012, the DFW Midstream system had five primary interconnections with third-party, intrastate pipelines that enables the Company to connect its customers, directly or indirectly, with the natural gas market hubs of Waha, Carthage, and Katy in Texas, and Perryville and Henry Hub in Louisiana. As of September 20, 2012, the DFW Midstream system gathered an average of approximately 325 million cubic feet per day from seven producers.

The Company competes with Access Midstream Partners, L.P., Crestwood Midstream Partners LP, Energy Transfer Partners, L.P., Williams Partners L.P., Energy Transfer Partners, L.P. and Enterprise Products Partners L.P.

Advisors' Opinion:

• [By Matt DiLallo]

  Midstream operator,�Summit Midstream Partners (NYSE: SMLP  ) is expanding its reach after it announced two separate natural gas gathering acquisitions last week. The company is spending $460 million to acquire assets in the Bakken and Marcellus in unrelated deals. Let's take a closer look and the deals and what both mean for investors.

Best High Tech Stocks To Watch Right Now: Impala Platinum Holdings Ltd (IMPUY.PK)

Impala Platinum Holdings Limited (Implats) is a producer of platinum group metals (PGMs) and associated base metals. Implats has operations on the PGM-bearing orebodies of the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. PGMs include platinum, and the associated by-products, palladium, rhodium, ruthenium, iridium and gold usually occur in association with nickel and copper. As of June 30, 2012, the Company�� holdings in various mining and exploration activities included Impala Platinum Limited (100%), which includes PGM mining, processing and refining; Impala Refining Services Limited (100%), which is engaged in purchase of concentrate and/or smelter matte; Impala Chrome (Pty) Limited (100%) and Makgomo Chrome (Pty) Limited (50%), which are engaged in purchase of chrome in tailings, and Zimplats Holdings Limited (86.9%), Afplats (Pty) Limited (74%), Marula Platinum (Pty) Limited (73%), Mimosa Investments Limited (50%) and Two Rivers Platinum (Pty) Limited (45%), which are engaged in PGM mining.

Impala Platinum

Impala Platinum, Implats��primary operational unit, has operations situated on the Impala lease area on the western limb of the Bushveld Complex near Rustenburg in South Africa, and in Springs east of Johannesburg. Impala holds contiguous mining rights and prospecting rights for a total area of 260 square kilometres. Operations comprise 14 operational shaft systems, five of which have underground decline systems.

Zimplats Holdings Limited

Zimplats Holdings Limited (Zimplats) is 87% owned by Implats and is located on the Hartley Geological Complex on the Zimbabwean Great Dyke south-west of Harare. Zimplats operates three underground mines and a concentrator at Ngezi. The Selous Metallurgical Complex (SMC), located some 77 kilometer north of the mine, comprises a concentrator and a smelter. The Company also owns the Hartley Platinum Mine situated at the SMC, which is under care and maintenance.

Marula Platin! um Limited

Marula Platinum Limited (Marula) is 73% owned by Implats. Marula is located in the Limpopo Province, some 50 kilometres north of Burgersfort. The operation consists of two on-reef decline shafts, one off-reef conventional decline and a concentrator plant.

Mimosa

Mimosa is wholly owned by Mimosa Investments Limited, a Mauritius-based company jointly held by Implats and Aquarius Platinum Limited (Aquarius) in a 50:50 joint-venture. Mimosa is located on the Wedza Geological Complex on the Zimbabwean Great Dyke east of Bulawayo. The operation comprises a shallow underground mine, accessed by a decline shaft, and a concentrator.

The Two Rivers Platinum Mine

The Two Rivers Platinum Mine (Two Rivers) is a joint venture between African Rainbow Minerals (ARM) (55%) and Impala Platinum Holdings Limited (Implats) (45%). The operation is situated on the farm Dwarsrivier on the southern part of the eastern limb of the Bushveld Igneous Complex in Mpumalanga, South Africa. The operation consists of two on-reef decline shafts and a concentrator.

Impala Refining Services (IRS)

IRS products include flotation concentrates from Marula, Mimosa and Two Rivers, as well as Aquarius��Marikana, Everest mine and Blue Ridge mines (on care and maintenance) and Eastern Platinum�� Crocodile River mine; furnace matte from Zimplats; spent autocatalysts from A-1 Specialised Services and Supplies Inc. for recycling, and selected base metal residues and other secondary materials.

Advisors' Opinion:

• [By Zacks Investment Research]

  It is hard to find a good play in the Zacks Industry of mining non-ferrous metals, as the industry currently has a rank of 247 out of 261. In fact, in our five mining industries, there are only two No. 1-Ranked stocks: Brigus Gold (BRD) and Impala (IMPUY.PK). Both of these are in struggling industries, but they have proven to be best-in-class thanks to improving earnings estimates. Plus, both have seen their ranks surge from holds (or worse) up to strong buy territory, suggesting either of these names might be better picks than the struggling SCCO at this time.

Best High Tech Stocks To Watch Right Now: Marine Products Corp (MPX)

Marine Products Corporation (Marine Products), incorporated on August 31, 2000, designs, manufactures and sells recreational fiberglass powerboats in the sportboat, deckboat, cruiser, sport yacht and sport fishing markets. The Company sells its products to a network of 135 domestic and 69 international independent authorized dealers. The Company focuses to remain a manufacturer of recreational powerboats for sale to a range of consumers globally. The Company manufactures Chaparral sterndrive and inboard-powered pleasure boats including H2O Sport and Fish & Ski boats, SSi and SSX Sportboats, Sunesta Sportdecks and Xtreme Tow boats, Signature Cruisers, Premiere Sport Yachts and Robalo outboard sport fishing boats. The Company offers a range of products to the family recreational, cruiser and sport yacht markets through its Chaparral brand, and to the sport fishing market through its Robalo brand.

The Company's products include Chaparral - H2O Sport Series, which is a fiberglass multipurpose runabouts; Chaparral - SSi Wide tech, which is a fiberglass closed deck runabouts; Chaparral - SSX Sportdecks, which is a fiberglass bowrider crossover sportboats; Chaparral - Sunesta Xtreme Tow Boats, which is a fiberglass pleasure boats; Chaparral - Signature Cruisers, which is a fiberglass, accommodation-focused cruisers; Chaparral - Premiere Sport Yacht, which is a fiberglass sport yacht, and Robalo - Sport Fishing Boats, which is a sport fishing boats for freshwater lakes or saltwater use. Domestic sales are made through approximately 74 Chaparral dealers, 16 Robalo dealers and 45 dealers that sell both brands located in markets throughout the United States. Marine Products also has 69 international dealers.

The Company competes with Sea Hunt, Sea Fox, Grady-White, Boston Whaler, Everglades and Parker.

Advisors' Opinion:

• [By Sean Williams]

  Sink or swim
  Sometimes the best short-sale opportunities are small, under-the-radar companies. One that I feel fits the bill perfectly is fiberglass boat maker Marine Products (NYSE: MPX  ) .

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Marine Products (NYSE: MPX  ) , whose recent revenue and earnings are plotted below.